GNMX — AEVI GENOMIC MEDICINE INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 1 SEC-registered investment managers reported holding GNMX (AEVI GENOMIC MEDICINE INC) in their latest 13F filings, with a combined reported value of $386.58K across 12.44K shares. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of AEVI GENOMIC MEDICINE INC (GNMX) include GTS SECURITIES LLC, ranked by reported 13F value among the 1 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q2 2026 | 1 | 12.44K | $386.58K | — |
| Q4 2019 | 3 | 2.68M | $391.00K | +9.1% |
| Q3 2019 | 3 | 2.46M | $369.00K | +21.6% |
| Q2 2019 | 3 | 2.02M | $323.00K | +74.6% |
| Q1 2019 | 3 | 1.16M | $227.00K | +371.7% |
| Q4 2018 | 3 | 245.48K | $171.00K | +16.9% |
| Q3 2018 | 3 | 209.97K | $258.00K | +1.9% |
| Q2 2018 | 3 | 206.07K | $229.00K | -12.3% |
Over the 8 quarters shown, institutional share counts decreased 94% in aggregate (Q2 2018 → Q2 2026); the largest single-quarter swing was Q1 2019 (+371.7%).
Top Institutional Holders (Q2 2026) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.44K | $386.58K | 0.01% | New |
New Positions (Q2 2026)
- GTS SECURITIES LLC 12.44K sh · $386.58K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 1 funds)
| Fund | Q2 2026 |
|---|---|
| GTS SECURITIES LLC | 12.44K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold GNMX?
As of 2026-Q2, 1 institutional funds reported holding GNMX (AEVI GENOMIC MEDICINE INC) in SEC 13F filings, with a combined reported value of $386.58K.
How many shares of GNMX do institutions own?
13F filers reported 12.44K shares of GNMX, worth $386.58K in aggregate at the end of 2026-Q2.
Is institutional ownership of GNMX rising or falling?
No prior-quarter baseline is available for a directional read.
Who are the top institutional holders of GNMX?
The largest 13F holders are GTS SECURITIES LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of AEVI GENOMIC MEDICINE INC?
The major shareholders of AEVI GENOMIC MEDICINE INC (GNMX) by reported 13F value are GTS SECURITIES LLC, among 1 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.